InvestmentJul 21, 2026, 10:48 PM
Dyne Therapeutics Prices Upsized Public Offering at $20.50/Share
AI Summary
Dyne Therapeutics, Inc. announced the pricing of an upsized underwritten public offering of 18,300,000 shares of its common stock at $20.50 per share. The offering is expected to generate gross proceeds of $375,150,000 for the company. Dyne has also granted the underwriters an option to purchase up to an additional 2,745,000 shares. The offering is anticipated to close around July 23, 2026.
Key Highlights
- Dyne Therapeutics priced an upsized underwritten public offering of 18,300,000 shares of common stock.
- The public offering price is $20.50 per share.
- Gross proceeds are expected to be $375,150,000 before deductions.
- Dyne granted underwriters a 30-day option to purchase up to an additional 2,745,000 shares.
- The offering is expected to close on or about July 23, 2026.
- Morgan Stanley, Jefferies, Evercore ISI, LifeSci Capital, and Raymond James are joint book-running managers.
Price Impact
More from DYN